Literature DB >> 17548156

High dopamine turnover in the brains of Sandy mice.

Tomotaka Murotani1, Tomoko Ishizuka, Satoko Hattori, Ryota Hashimoto, Shinsuke Matsuzaki, Atsushi Yamatodani.   

Abstract

Schizophrenia is a chronic mental disorder and patients with this disease show positive and negative symptoms, cognitive dysfunction, and deficits in the processing of emotion. From previous studies, dopaminergic neurons are believed to be related to schizophrenic symptoms. Dysbindin (DTNBP1: dystrobrevin binding protein 1) gene is a susceptibility gene for schizophrenia, but the involvement of this gene in the dopaminergic tone remains unknown. In this paper, we studied regional contents of dopamine and its metabolite in the Sandy (Sdy) mouse which expresses no dysbindin protein. The brains of Sdy and wild-type (WT) mice were dissected into ten regions and dopamine (DA) and homovanillic acid (HVA) in each region were determined. DA contents were significantly lower in the cortex, hippocampus, and hypothalamus of Sdy mice than WT mice, while HVA contents showed no differences between the strains. Western blot analysis revealed there were no differences in the amount of tyrosine hydroxylase (TH) in the midbrain (MB) of both strains. The ratios of DA to HVA, which is an index of DA turnover, were higher in the cortex and the hippocampus, but not in the hypothalamus. These data demonstrate that DA turnover in the specific regions of the brain of the Sdy mouse was increased, and the Sdy mouse is a possible useful candidate animal for studying the pathogenic mechanism of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548156     DOI: 10.1016/j.neulet.2007.05.019

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

2.  Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia.

Authors:  Yong Chen; Sookhee Bang; Mary F McMullen; Hala Kazi; Konrad Talbot; Mei-Xuan Ho; Greg Carlson; Steven E Arnold; Wei-Yi Ong; Sangwon F Kim
Journal:  Mol Neurobiol       Date:  2016-02-12       Impact factor: 5.590

3.  Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.

Authors:  W Bailey Glen; Bryant Horowitz; Gregory C Carlson; Tyrone D Cannon; Konrad Talbot; J David Jentsch; Antonieta Lavin
Journal:  Hippocampus       Date:  2013-11-12       Impact factor: 3.899

4.  Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice.

Authors:  Jana Drgonova; Donna Walther; G Luke Hartstein; Mohammad O Bukhari; Michael H Baumann; Jonathan Katz; Frank Scott Hall; Elizabeth R Arnold; Shaun Flax; Anthony Riley; Olga Rivero-Martin; Klaus-Peter Lesch; Juan Troncoso; Barbara Ranscht; George R Uhl
Journal:  Mol Med       Date:  2016-08-18       Impact factor: 6.354

5.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 6.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

7.  Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain.

Authors:  Hiroaki Okuda; Ryusuke Kuwahara; Shinsuke Matsuzaki; Shingo Miyata; Natsuko Kumamoto; Tsuyoshi Hattori; Shoko Shimizu; Kohei Yamada; Keisuke Kawamoto; Ryota Hashimoto; Masatoshi Takeda; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

Review 8.  Synapse-specific contributions in the cortical pathology of schizophrenia.

Authors:  Saurav Seshadri; Mariela Zeledon; Akira Sawa
Journal:  Neurobiol Dis       Date:  2013-01-18       Impact factor: 5.996

9.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

10.  Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA- dependent protein kinase complex in an isoform-dependent manner.

Authors:  Satoko Oyama; Hidekuni Yamakawa; Noboru Sasagawa; Yoshio Hosoi; Eugene Futai; Shoichi Ishiura
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.